Faculty Publications

Phase II trial of dasatinib in triple-negative breast cancer: results of study CA 180059

Finn RS, Bengala C, Ibrahim N, Strauss LC, Fairchild J, Sy O, Roche H, Sparano J, Goldstein LJ

Phase II trial of dasatinib in triple-negative breast cancer: results of study CA 180059

Cancer Res. 2009;69(2):237S-237S.

Abstract

Last updated on Saturday, November 21, 2009